-
Generative Artificial Intelligence Models for Developing Neuroimaging Markers of Psychiatric Disorders Biol. Psychiatry (IF 9.6) Pub Date : 2025-05-08
Chadi G. Abdallah, David van Dijk -
Designing Clinical Trials for an Inflammatory Subtype of Major Depressive Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2025-04-10
Andrew H. Miller, Jennifer C. Felger, Ebrahim Haroon -
Biological Psychiatry: Preserving the Promise Biol. Psychiatry (IF 9.6) Pub Date : 2025-04-09
John H. Krystal, Cameron S. Carter, Carrie E. Bearden, Deanna M. Barch, Editors and Editorial Boards of Biological Psychiatry Biological Psychiatry: Cognitive Neuroscience and Neuroimaging and Biological Psychiatry: Global Open Science, Editorial Committee of the Biological Psychiatry family of journals, Society of Biological Psychiatry -
Preclinical Models for Schizophrenia and Sleep Oscillations: From Biomarkers to Mechanisms Biol. Psychiatry (IF 9.6) Pub Date : 2025-04-08
Vladyslav V. Vyazovskiy, David M. Bannerman -
G Protein Inactivation as a Mechanism for Addiction Treatment Biol. Psychiatry (IF 9.6) Pub Date : 2025-04-04
Carlie Neiswanger, Micaela V. Ruiz, Kandace Kimball, Justin Daho Lee, Benjamin B. Land, Andre Berndt, Charles ChavkinThe endogenous dynorphin/kappa opioid receptor (KOR) system in the brain mediates the dysphoric effects of stress, and KOR antagonists may have therapeutic potential for the treatment of drug addiction, depression, and psychosis. One class of KOR antagonists, the long-acting norbinaltorphimine (norBNI)–like antagonists, have been suggested to act by causing KOR inactivation through a c-Jun-kinase mechanism
-
Integrating Aversive Memories in the Basolateral Amygdala Biol. Psychiatry (IF 9.6) Pub Date : 2025-04-04
Jianfeng Liu, Michael S. Totty, Hugo Bayer, Stephen MarenDecades of research have established a critical role of the basolateral complex of the amygdala (BLA) in the encoding and storage of aversive memories. Much of this work has utilized Pavlovian fear conditioning procedures in which animals experience a single aversive event. Although this effort has produced great insight into the neural mechanisms that support fear memories for an isolated aversive
-
The Metabolomic Signature of Childhood Trauma Biol. Psychiatry (IF 9.6) Pub Date : 2025-04-04
Camille Souama, Femke Lamers, Yuri Milaneschi, Rick Jansen, Christiaan H. Vinkers, Erik J. Giltay, Boadie W. Dunlop, Rima Kaddurah-Daouk, Brenda W.J.H. Penninx, Mood Disorder Precision Medicine ConsortiumAlthough childhood trauma is an important risk factor for various diseases, the underlying biological mechanisms remain insufficiently understood. To deepen this understanding, we investigated the wide-spectrum metabolomic signature of childhood trauma exposure in a large adult cohort.
-
Brain Network Resilience and Cognitive Function in Patients With First-Episode Schizophrenia Spectrum Disorders Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-30
Soyolsaikhan Odkhuu, XiaoChen Tang, Woo-Sung Kim, YanYan Wei, LiHua Xu, HuiRu Cui, YingYing Tang, JiJun Wang, Keon-Hak Lee, Nam-In Kang, TianHong Zhang, Young-Chul ChungFirst-episode schizophrenia spectrum disorders (FESSDs) are associated with significant cognitive impairment that affects daily functioning. While these deficits are well documented, the neural mechanisms underlying the cognitive impairment in FESSDs remain limited. Because the structure robustness and resilience of the brain network in healthy populations are reported to be associated with cognitive
-
Prophylactic Ketamine: Current Knowledge and Future Directions Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-28
Astrid M. Cardona-Acosta, Lyonna F. Parise, Carlos A. Bolaños-Guzmán, Eric M. PariseThe prevalence of stress-induced disorders, including depression, anxiety, posttraumatic stress disorder, and postpartum depression, has been increasing, while current treatment approaches are limited. As a result, researchers are exploring alternative treatments that include ketamine as a prophylactic against these disorders. This review provides an overview of the current knowledge on the use of
-
Novel Multimodal Precision Medicine Approaches and the Relevance of Developmental Trajectories in Bipolar Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-27
Olav B. Smeland, Cecilie Busch, Ole A. Andreassen, Mirko ManchiaThere is a pressing need to establish objective measures to improve diagnosis, prediction, prevention, and treatment of bipolar disorder (BD). Multimodal artificial intelligence (AI) tools could provide these means by incorporating various layers of data orthogonally related to BD, including genomics and other omics, environmental exposures, imaging measures, electronic health records, cognition, sensing
-
Neurochemical and Circuit Heterogeneity of Cognition-Modulating Prefrontal Corticotropin-Releasing Factor Neurons Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-27
Spencer K. Cooke, Andrea J. Martin, Robert C. Spencer, Shannon E. Nicol, Craig W. BerridgeImpairment of prefrontal cortex (PFC)–dependent cognition is associated with multiple psychiatric disorders. Development of more effective treatments for this form of cognitive dysfunction is hindered by our limited understanding of the neurobiology underlying PFC-dependent cognition. We previously identified a robust population of corticotropin-releasing factor (CRF) neurons in the caudal dorsomedial
-
Mendelian Randomization Reveals Causalities Between DNA Methylation and Schizophrenia Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-27
Danni Wang, Danyang Li, Xinglun Dang, Changgai Mu, Chang Liu, Yong Zeng, Yonggui Yuan, Zhaowei Teng, Yifan Li, Xiong-Jian LuoEpigenetic factors (such as DNA methylation) have been widely reported to be associated with schizophrenia (SCZ). However, the causal relationships between epigenetic factors and SCZ remain largely unknown.
-
Deep Brain Stimulation Response Circuits in Obsessive-Compulsive Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-20
Andreas Horn, Ningfei Li, Garance M. Meyer, Ron Gadot, Nicole R. Provenza, Sameer A. ShethIn the field of deep brain stimulation (DBS), 2 major themes are currently making significant progress. The first of these is the framework of connectomic DBS, in which circuits that are associated with improvements of specific symptoms are described and targeted to improve and potentially personalize treatment. The second theme is related to the concept of brain sensing and adaptive DBS, which are
-
Astrocytes Control Cocaine-Induced Synaptic Plasticity and Reward Through the Matricellular Protein Hevin Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-18
Raphaële Mongrédien, Augusto Anesio, Gustavo J.D. Fernandes, Andrew L. Eagle, Steeve Maldera, Cuong Pham, Séverine Robert, Fernando Bezerra, Adèle Vilette, Paula C. Bianchi, Clara Franco, Franck Louis, Carole Gruszczynski, Marie-Laure Niépon, Catalina Betancur, Amaia M. Erdozain, Alfred J. Robison, Antony A. Boucard, Fabio C. Cruz, Dongdong Li, Nicolas Heck, Sophie Gautron, Vincent VialouAstrocytes in the nucleus accumbens (NAc) play a dynamic role in regulating synaptic plasticity induced by drugs of abuse through modulation of glutamatergic neurotransmission. Astrocyte-secreted factors may also contribute to the reprogramming of brain circuitry that leads to drug-seeking behavior. Here, we investigated the role of astrocyte Ca2+ signals in vivo and of the astrocyte-secreted protein
-
Low Stability and Specificity of Polygenic Risk Scores for Major Psychiatric Disorders Limit Their Clinical Utility Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-18
Josephine Mollon, Laura M. Schultz, Emma E.M. Knowles, Sebastien Jacquemont, David C. Glahn, Laura AlmasyThere has been little examination of the stability and validity of polygenic risk scores (PRSs), i.e., whether individuals identified as high risk for a disorder with one PRS are identified as high risk with another PRS and whether high-risk individuals have the disorder.
-
-
Prosocial Helping Behavior: Conceptual Issues and Neural Mechanisms Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-14
Nicole Rigney, Weizhe HongProsocial helping behavior, characterized by voluntary actions taken to benefit others, plays a vital role in promoting cooperation and maintaining social bonds across human and animal social groups. In this review, we examine key conceptual issues surrounding prosocial behavior, focusing specifically on targeted helping and comforting actions. We outline the behavioral paradigms used to study these
-
Early Manifestations of Neurodevelopmental Copy Number Variants in Children: A Population-Based Investigation Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-14
Charlotte A. Dennison, Joanna Martin, Amy Shakeshaft, Lucy Riglin, Victoria Powell, George Kirov, Michael J. Owen, Michael C. O’Donovan, Anita ThaparThere is clinical interest in recognizing copy number variants (CNVs) in children because many have immediate and long-term health implications. Neurodevelopmental (ND) CNVs are associated with intellectual disability, autism spectrum disorder (ASD), and attention-deficit/hyperactivity disorder (ADHD), conditions typically diagnosed by medical practitioners. However, ND CNVs may have additional, early
-
Immune-Developmental Processes Contribute to Schizophrenia Risk: Insights From a Genetic Overlap Study With Height Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-10
Cato Romero, Christiaan de Leeuw, Marijn Schipper, Bernardo de A.P.C. Maciel, Martijn P. van den Heuvel, Rachel M. Brouwer, August B. Smit, Frank Koopmans, Danielle Posthuma, Sophie van der SluisShorter stature has been phenotypically linked to increased prevalence of schizophrenia (SCZ), but the nature of this association is unknown.
-
Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-08
Jonathan Repple, Maximilian Bayas, Chiara Möser, Nene F. Kobayashi, Andreas ReifAfter decades of limited progress in depression treatment, recent advancements have sparked renewed interest in developing novel antidepressants, particularly rapid-acting antidepressants (RAADs). Despite these promising developments, there remains a significant gap in research on bipolar depression. While several antipsychotics have been investigated for their efficacy in bipolar depression due to
-
Does the Influence of Low Body Mass Index on Diagnosis Complicate Genetic Studies of the Role of Cardiometabolic Traits in Liability to Anorexia Nervosa? Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-07
William R. Reay, Kirrilly M. Pursey, Jackson G. ThorpAnorexia nervosa (AN) is an eating disorder for which the underlying etiology remains mostly uncharacterized. Large-scale genetic studies of AN suggest a relationship between AN liability and cardiometabolic traits, such as lipid and glycemic biology, which may reveal novel treatment targets through pharmacological or nutritional interventions. However, the role of body mass index (BMI) in the diagnosis
-
A Cross-Generational Methylomic Signature of Infant Maltreatment in Newborn Rhesus Macaques Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-05
Roy Lardenoije, Michelle N.C.A. Smulders, Elyse L. Morin, Brittany R. Howell, Dora Guzman, Jerrold S. Meyer, Kerry J. Ressler, Mar Sánchez, Torsten KlengelEarly-life adversity (ELA) results in detrimental physical and mental health outcomes. The impact of ELA can reverberate across generations, with epigenetic modifications being one of the proposed biological correlates of exposure to ELA. Here, we bridge the translational gap between rodent models and clinical studies by utilizing a nonhuman primate model to study the cross-generational epigenetic
-
Effects of Long-Term Cocaine Self-Administration on Kappa Opioid Receptors in Socially Housed Cynomolgus Monkeys as Assessed With Positron Emission Tomography Imaging and Neuronally Derived Exosomes Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-05
Bernard N. Johnson, Mia I. Allen, Susan H. Nader, Kiran Kumar Solingapuram Sai, Ashish Kumar, Yixin Su, Sangeeta Singh, Songye Li, Yiyun Huang, Gagan Deep, Michael A. NaderThe current study utilized positron emission tomography (PET) imaging to examine how long-term cocaine self-administration (SA) and time off cocaine affected kappa opioid receptor (KOR) availability in the brain of previously cocaine-naïve monkeys. In addition, neuronally derived small extracellular vesicles (NDEs) were measured from plasma to identify peripheral measures of KORs.
-
Effects of the KCNQ (Kv7) Channel Opener Ezogabine on Resting-State Functional Connectivity of Striatal Brain Reward Regions, Depression, and Anhedonia in Major Depressive Disorder: Results From a Randomized Controlled Trial Biol. Psychiatry (IF 9.6) Pub Date : 2025-03-04
Avijit Chowdhury, Sarah Boukezzi, Sara Costi, Sara Hameed, Yael Jacob, Ramiro Salas, Dan V. Iosifescu, Ming-Hu Han, Alan Swann, Sanjay J. Mathew, Laurel Morris, James W. MurroughMajor depressive disorder (MDD) is a leading cause of disability worldwide, with available treatments often showing limited efficacy. Recent research suggests that targeting specific subtypes of depression and understanding the underlying brain mechanisms can improve treatment outcomes. This study investigates the potential of the potassium KCNQ (Kv7) channel opener ezogabine to modulate the resting-state
-
Integrative Genomics Approach Identifies Glial Transcriptomic Dysregulation and Risk in the Cortex of Individuals With Alcohol Use Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-28
Anna S. Warden, Nihal A. Salem, Eric Brenner, Greg T. Sutherland, Julia Stevens, Manav Kapoor, Alison M. Goate, R. Dayne MayfieldAlcohol use disorder (AUD) is a prevalent neuropsychiatric disorder that is a major global health concern, affecting millions of people worldwide. Previous studies of AUD used underpowered single-cell analysis or bulk homogenates of postmortem brain tissue, which obscure gene expression changes in specific cell types. Therefore, we sought to conduct the largest-to-date single-nucleus RNA sequencing
-
Amygdala Hyperactivity in Posttraumatic Stress Disorder: Disentangling Predisposing From Consequential Factors Using a Prospective Longitudinal Design Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-28
Lycia D. de Voogd, Mahur M. Hashemi, Wei Zhang, Reinoud Kaldewaij, Saskia B.J. Koch, Vanessa A. van Ast, Floris Klumpers, Karin RoelofsSubstantial interindividual differences exist in the vulnerability to develop posttraumatic stress disorder (PTSD) symptoms following trauma exposure. Identification of neurocognitive risk markers for PTSD symptoms could aid early assessment and identification of preventive intervention targets for PTSD, particularly in high-risk professionals. Therefore, large prospective longitudinal studies with
-
Emergence and Dynamics of Delusions and Hallucinations Across Stages in Early Psychosis Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-26
Catalina Mourgues-Codern, David Benrimoh, Jay Gandhi, Emily A. Farina, Raina Vin, Tihare Zamorano, Deven Parekh, Ashok Malla, Ridha Joober, Martin Lepage, Srividya N. Iyer, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead, Barbara Cornblatt, Matcheri Keshavan, William S. Stone, Daniel H. Mathalon, Diana O. Perkins, Elaine F. Walker, Tyrone D. Cannon, Scott W. Woods, Jai L. Shah, Albert R. PowersHallucinations and delusions are often grouped together as positive symptoms of psychosis. However, recent evidence suggests that they may be driven by distinct computational and neural mechanisms. Examining the time course of their emergence may provide insights into the relationship between these underlying mechanisms.
-
Dissecting Schizophrenia Biology Using Pleiotropy With Cognitive Genomics Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-22
Upasana Bhattacharyya, Jibin John, Todd Lencz, Max LamGiven the increasingly large number of loci discovered by psychiatric genome-wide association studies (GWASs), specification of the key biological pathways that underlie these loci has become a priority for the field. We have previously leveraged the pleiotropic genetic relationships between schizophrenia (SCZ) and 2 cognitive phenotypes (educational attainment and cognitive task performance) to differentiate
-
The Neuropsychiatric Checklist for Autoimmune Psychosis: A Narrative Review Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-21
Ludger Tebartz van Elst, Kimon Runge, Philipp T. Meyer, Horst Urbach, Nils Venhoff, Harald PrüssAutoimmune encephalitis (AE) is a rapidly evolving topic in both neurology and psychiatry. A recent international consensus article defined criteria for possible, probable, and definite autoimmune psychosis (AP) inspired by the principles established in neurology for the definition of AE. This has stimulated much clinical research on AP but also criticism of the validity of the criteria for possible
-
Incorporating Polygenic Liability and Family History for Predicting Psychiatric Diseases in the Taiwan Biobank Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-19
Shi-Heng Wang, Yen-Chen A. Feng, Mei-Chen Lin, Chi-Fung Cheng, Mei-Hsin Su, Chia-Yen Chen, Chi-Shin Wu, Chun Chieh FanIn this study, we investigated the interplay between molecular measures of polygenic risk scores (PRSs) and conventional measures of family history (FH) on the risk of 4 psychiatric disorders: schizophrenia (SCZ), bipolar disorder (BPD), major depressive disorder (MDD), and obsessive-compulsive disorder (OCD) in community samples of East Asian populations. We examined the individual and joint associations
-
Mapping the Genetic Landscape of Psychiatric Disorders With the MiXeR Toolset Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-19
Dennis van der Meer, Guy Hindley, Alexey A. Shadrin, Olav B. Smeland, Nadine Parker, Anders M. Dale, Oleksandr Frei, Ole A. AndreassenPsychiatric disorders have complex genetic architectures with substantial genetic overlap across conditions, which may partially explain their high levels of comorbidity. This presents significant challenges to research. Genome-wide association studies (GWASs) have uncovered hundreds of loci associated with single disorders, but the genetic landscape of psychiatric disorders has remained largely obscure
-
Neurobiological Perturbations in Bipolar Disorder Compared With Schizophrenia: Evidence From Cell Cultures and Brain Organoids Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-19
Ibrahim A. Akkouh, Jordi Requena Osete, Attila Szabo, Ole A. Andreassen, Srdjan DjurovicBipolar disorder (BD) and schizophrenia (SCZ) are uniquely human disorders with a complex pathophysiology that involves adverse neuropathological events in brain development. High disease polygenicity and limited access to live human brain tissue make these disorders exceedingly challenging to study mechanistically. Cellular cultures and brain organoids generated from human-derived pluripotent stem
-
Reply to: Methodological and Interpretational Issues in the PsyRiskMR Database Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-19
Xiaoyan Li, Junfeng Xia -
Methodological and Interpretational Issues in the PsyRiskMR Database Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-19
Jiawei Zhao -
Society of Biological Psychiatry’s 2025 Meeting Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-18
Sophia Frangou M.D. Ph.D., Dost Öngür M.D. Ph.D. -
Global Diversity in Bipolar Disorder: The Role of Cultural and Social Differences With a View to Genomics Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-14
Janice M. Fullerton, Markos TesfayeAs global gene discovery efforts move away from a historic Eurocentric focus and advance toward embracing more diverse populations, consideration of sociocultural aspects of bipolar disorder (BD) become critical to their success. Diversity can be leveraged to accelerate gene discovery, via different patterns of linkage disequilibrium that lead to greater resolution of mapping association signals, and
-
Mapping Structural Neuroimaging Trajectories in Bipolar Disorder: Neurobiological and Clinical Implications Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-14
Nadine Parker, Christopher R.K. ChingNeuroimaging is a powerful noninvasive method for studying brain alterations in bipolar disorder (BD). To date, most neuroimaging studies of BD have included smaller cross-sectional samples reporting case versus control comparisons, revealing small to moderate effect sizes. In this narrative review, we discuss the current state of structural neuroimaging studies using magnetic resonance imaging, which
-
Toward Understanding and Halting Legacies of Trauma Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-14
William Wesley Taylor, Laura Korobkova, Nabeel Bhinderwala, Brian George DiasEchoes of natural and anthropogenic stressors not only reverberate within the physiology, biology, and neurobiology of the generation directly exposed to them but also within the biology of future generations. With the intent of understanding this phenomenon, significant efforts have been made to establish how exposure to psychosocial stress, chemicals, over- and undernutrition, and chemosensory experiences
-
Affective and Social Predictors of Food Consumption During the COVID-19 Lockdown Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-14
Ana Stijovic, Paul Forbes, Ekaterina Pronizius, Anja Feneberg, Giulio Piperno, Urs M. Nater, Claus Lamm, Giorgia SilaniCOVID-19 lockdowns were linked to a surge in unhealthy food–related behaviors, potentially as an attempt to cope with disrupted social homeostasis. Here, we tested bidirectional associations between momentary psychological states and prospective food consumption and the moderation of these associations by quality and quantity of social interactions.
-
Prediction of Treatment Outcome in Bipolar Disorder: When Can We Expect Clinical Relevance? Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-13
Katie Scott, Anouar Khayachi, Martin Alda, Abraham NunesLong-term pharmacological treatment is the cornerstone of the management of bipolar disorder (BD). Clinicians typically select mood-stabilizing medications from among several options through trial and error. This process could be optimized by using robust predictors of treatment response. We review clinical features and biological markers studied in relation to outcome of long-term treatment of BD
-
The Drug Discovery Drought in Bipolar Disorder: Barriers and Solutions Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-13
Jee Hyun Kim, Ken Walder, Bruna Panizzutti, Lana J. Williams, Michael Berk -
The Promise of Investigating Neural Variability in Psychiatric Disorders Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-13
Konstantinos Tsikonofilos, Arvind Kumar, Konstantinos Ampatzis, Douglas D. Garrett, Kristoffer N.T. MånssonResearchers have begun to use the synergy of psychiatry and neuroscience to identify biomarkers that can be used to diagnose mental health disorders, predict their progression, and forecast treatment efficacy. However, biomarkers have achieved limited success to date, potentially due to a narrow focus on specific aspects of brain signals. This highlights a critical need for methodologies that can fully
-
Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for Psychosis Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-07
Samuel R. Knight, Leyla Abbasova, Yashar Zeighami, Justine Y. Hansen, Daniel Martins, Fernando Zelaya, Ottavia Dipasquale, Thomas Liu, David Shin, Matthijs Bossong, Matilda Azis, Mathilde Antoniades, Oliver D. Howes, Ilaria Bonoldi, Alice Egerton, Paul Allen, Owen O’Daly, Philip McGuire, Gemma ModinosThe brain integrates multiple scales of description, from the level of cells and molecules to large-scale networks and behavior. Understanding relationships across these scales may be fundamental to advancing understanding of brain function in health and disease. Recent neuroimaging research has shown that functional brain alterations that are associated with schizophrenia spectrum disorders (SSDs)
-
Epigenetic Control of an Auxiliary Subunit of Voltage-Gated Sodium Channels Regulates the Strength of Drug-Cue Associations and Relapse-Like Cocaine Seeking Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-07
Daniel J. Wood, Evgeny Tsvetkov, Susana Comte-Walters, Colin L. Welsh, Michelle Bloyd, Timothy G. Wood, Rose Marie Akiki, Ethan M. Anderson, Rachel D. Penrod, Lalima K. Madan, Lauren E. Ball, Makoto Taniguchi, Christopher W. CowanRepeated use of addictive drugs produces long-lasting and prepotent drug-cue associations that increase vulnerability for relapse in individuals with a substance use disorder. Epigenetic factors, such as HDAC5 (histone deacetylase 5), play a key role in regulating the formation of drug-cue associations, but the underlying mechanisms remain unclear.
-
Empirical Classification of Neuropsychiatric Symptoms and Association of Classes With Diagnostic Progression and Cognitive Decline in Mild Cognitive Impairment and Alzheimer’s Disease Populations Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-06
Jong-Il Park, Seonjoo Lee, Benjamin Huber, Davangere P. Devanand, Hyun Kim, Terry E. Goldberg, Alzheimer’s Disease Neuroimaging InitiativeThe current study aimed to identify classes of cognitively impaired older individuals based on their neuropsychiatric symptoms (NPSs) and to investigate the contribution of NPS class to cognitive decline and Alzheimer’s disease (AD) risk in mild cognitive impairment (MCI).
-
A Critical Role of Philanthropic Support in Paving the Way to Precision Medicine for Bipolar Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-06
Daniel L. Pham, Emily G. Baxi, Kelsey M. Barcomb, Veronica C. Beck, Katherine E. Burdick, Mark A. Frye, Eric J. Nestler, Cara M. Altimus -
Identification and External Validation of a Problem Cannabis Risk Network Biol. Psychiatry (IF 9.6) Pub Date : 2025-02-03
Sarah D. Lichenstein, Brian D. Kiluk, Marc N. Potenza, Hugh Garavan, Bader Chaarani, Tobias Banaschewski, Arun L.W. Bokde, Sylvane Desrivières, Herta Flor, Antoine Grigis, Penny Gowland, Andreas Heinz, Rüdiger Brühl, Jean-Luc Martinot, Marie-Laure Paillère Martinot, Eric Artiges, Frauke Nees, Dimitri Papadopoulos Orfanos, Luise Poustka, Sarah Hohmann, Nathalie Holz, Christian Baeuchl, Michael N. SmolkaCannabis use is common, particularly during emerging adulthood when brain development is ongoing, and its use is associated with harmful outcomes for a subset of people. An improved understanding of the neural mechanisms underlying risk for problem-level use is critical to facilitate the development of more effective prevention and treatment approaches.
-
Interneuron Loss and Microglia Activation by Transcriptome Analyses in the Basal Ganglia of Tourette Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-30
Yifan Wang, Liana Fasching, Feinan Wu, Milovan Suvakov, Anita Huttner, Sabina Berretta, Rosalinda Roberts, James F. Leckman, Thomas V. Fernandez, Alexej Abyzov, Flora M. VaccarinoTourette disorder (TS) is characterized by motor hyperactivity and tics that are believed to originate in the basal ganglia. Postmortem immunocytochemical analyses has revealed decreases in cholinergic (CH), as well as parvalbumin and somatostatin GABA (gamma-aminobutyric acid) interneurons (INs) within the caudate/putamen of individuals with TS.
-
Investigating the Contribution of Coding Variants in Alcohol Use Disorder Using Whole-Exome Sequencing Across Ancestries Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-30
Lu Wang, Henry R. Kranzler, Joel Gelernter, Hang ZhouAlcohol use disorder (AUD) is a leading cause of death and disability worldwide. There has been substantial progress in identifying genetic variants that underlie AUD. However, whole-exome sequencing studies of AUD have been hampered by the lack of available samples.
-
Comparative Perspectives on Neuropeptide Function and Social Isolation Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-30
Kenta Asahina, Moriel ZelikowskyChronic social isolation alters behavior across animal species. Genetic model organisms such as mice and flies provide crucial insight into the molecular and physiological effects of social isolation on brain cells and circuits. Here, we comparatively review recent findings regarding the function of conserved neuropeptides in social isolation in mice and flies. Analogous functions of 3 classes of
-
Two-Month Cognitive Changes Enhance Prediction of Nonremission in Clinical High-Risk Individuals Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-30
TianHong Zhang, YanYan Wei, XiaoChen Tang, LiHua Xu, HuiRu Cui, YeGang Hu, HaiChun Liu, ZiXuan Wang, Tao Chen, YingYing Tang, ZhengHui Yi, ChunBo Li, JiJun WangLongitudinal changes in cognitive function may be crucial in predicting clinical outcomes in clinical high-risk (CHR) individuals. In this study, we aimed to investigate the predictive value of baseline cognitive impairment and short-term cognitive changes for nonremission and conversion to psychosis in individuals at CHR for psychosis compared with healthy control individuals (HCs).
-
Hippocampal DNA Methylation Promotes Contextual Fear Memory Persistence by Facilitating Systems Consolidation and Cortical Engram Stabilization Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-27
Janina Kupke, Stefanos Loizou, C. Peter Bengtson, Carsten Sticht, Ana M.M. OliveiraLong-term fear memory storage involves gradual reorganization of supporting brain regions over time, a process termed systems consolidation. Memories initially rely on the hippocampus but gradually shift dependence to the neocortex. Although hippocampal activity drives this transfer, the molecular basis of systems consolidation is largely unknown. DNA methylation changes accompany persistent fear memory
-
Grasping Posttraumatic Stress Disorder From the Perspective of Psychoneuroimmunoendocrinology: Etiopathogenic Mechanisms and Relevance for Integrative Management Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-27
Oscar Fraile-Martinez, Cielo García-Montero, Miguel Ángel Álvarez-Mon, Carlos Casanova-Martín, Daniel Fernández-Faber, Marta Presa, Guillermo Lahera, Laura Lopez-Gonzalez, Raúl Díaz-Pedrero, José V. Saz, Melchor Álvarez-Mon, Miguel A. Sáez, Miguel A. OrtegaPosttraumatic stress disorder (PTSD) is a debilitating condition caused by exposure to traumatic events that affects 5% to 10% of the population, with increased prevalence among women and individuals in war zones. Beyond psychological symptoms, PTSD induces significant physiological changes across systems. Psychoneuroimmunoendocrinology (PNIE) offers a framework to explore these complex interactions
-
Nuclear Calcium Signaling in D1 Receptor–Expressing Neurons of the Nucleus Accumbens Regulates Molecular, Cellular, and Behavioral Adaptations to Cocaine Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-27
Estefani Saint-Jour, Marie-Charlotte Allichon, Andry Andrianarivelo, Enrica Montalban, Claire Martin, Lisa Huet, Nicolas Heck, Anna M. Hagenston, Aisha Ravenhorst, Mélanie Marias, Nicolas Gervasi, Faustine Arrivet, Adèle Vilette, Katleen Pinchaud, Sandrine Betuing, Thomas Lissek, Jocelyne Caboche, Hilmar Bading, Peter VanhoutteThe persistence of cocaine-evoked adaptations relies on gene regulations within the reward circuit, especially in the ventral striatum (i.e., nucleus accumbens [NAc]). Notably, activation of the ERK (extracellular signal-regulated kinase) pathway in the striatum is known to trigger a transcriptional program shaping long-term responses to cocaine. Nuclear calcium signaling has also been shown to control
-
Characterizing Brainstem GLP-1 Control of Sensory-Specific Satiety in Male and Female Rats Across the Estrous Cycle Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-22
Sarah V. Applebey, Allison G. Xiao, Erin P. Harris, Caleb Levine, Drew L. Belser, Caroline E. Geisler, Marise B. Parent, Debra A. Bangasser, Richard C. Crist, Benjamin C. Reiner, Matthew R. HayesMeal variety promotes overconsumption by delaying sensory-specific satiety (SSS), the transient reduction in reward value of a recently consumed food. Despite its role in meal cessation, the neuroendocrine mechanisms that underlie SSS are largely unknown.
-
Transcranial Direct Current Stimulation Improves Paranoia and Social Functioning in Schizophrenia: A Randomized Clinical Trial Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-22
Linlin Fan, Sara Carrico, Yiyi Zhu, Robert A. Ackerman, Amy E. PinkhamInnovative treatments for paranoia, which significantly impairs social functioning in schizophrenia spectrum disorders (SSDs), are urgently needed. The pathophysiology of paranoia implicates the amygdala–prefrontal cortex (PFC) circuits; thus, in this study, we systematically investigated whether transcranial direct current stimulation (tDCS) to the ventrolateral PFC can attenuate paranoia and improve
-
Alterations in Prefrontal Cortical Somatostatin Neurons in Schizophrenia: Evidence for Weaker Inhibition of Pyramidal Neuron Dendrites Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-21
Samuel J. Dienel, Kirsten L. Wade, Kenneth N. Fish, David A. LewisCertain cognitive processes require inhibition provided by the somatostatin (SST) class of GABA (gamma-aminobutyric acid) neurons in the dorsolateral prefrontal cortex (DLPFC). This inhibition onto pyramidal neuron dendrites depends on both SST and GABA signaling. Although SST messenger RNA (mRNA) levels are lower in the DLPFC in schizophrenia, it is not known whether SST neurons exhibit alterations
-
Speak and You Shall Predict: Evidence That Speech at Initial Cocaine Abstinence Is a Biomarker of Long-Term Drug Use Behavior Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-20
Carla Agurto, Guillermo A. Cecchi, Sarah King, Elif K. Eyigoz, Muhammad A. Parvaz, Nelly Alia-Klein, Rita Z. GoldsteinValid scalable biomarkers for predicting longitudinal clinical outcomes in psychiatric research are crucial for optimizing intervention and prevention efforts. Here, we recorded spontaneous speech from initially abstinent individuals with cocaine use disorder (iCUDs) for use in predicting drug use outcomes.
-
Descriptives and Genetic Correlates of Eating Disorder Diagnostic Transitions and Presumed Remission in the Danish Registry Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-17
Mohamed Abdulkadir, Janne Tidselbak Larsen, Loa Clausen, Christopher Hübel, Clara Albiñana, Laura M. Thornton, Bjarni J. Vilhjálmsson, Cynthia M. Bulik, Zeynep Yilmaz, Liselotte Vogdrup PetersenEating disorders (EDs) are serious psychiatric disorders with an estimated 3.3 million healthy life-years lost worldwide yearly. Understanding the course of illness, diagnostic transitions and remission, and their associated genetic correlates could inform both ED etiology and treatment. We investigated occurrences of ED transitions and presumed remission and their genetic correlates as captured by
-
Mapping the Cerebrospinal Fluid Proteome in Bipolar Disorder Biol. Psychiatry (IF 9.6) Pub Date : 2025-01-17
Andreas Göteson, Jessica Holmén-Larsson, Hatice Celik, Aurimantas Pelanis, Carl M. Sellgren, Timea Sparding, Erik Pålsson, Henrik Zetterberg, Kaj Blennow, Lina Jonsson, Johan Gobom, Mikael LandénBipolar disorder (BD) is a severe psychiatric condition with unclear etiology and no established biomarkers. Here, we aimed to characterize the cerebrospinal fluid (CSF) proteome in euthymic individuals with BD to identify potential protein biomarkers.